Allen, J., & Bradley, R
Peptides like Thymosin alpha-1 and a class of synthetic immune-modulatory peptides modulate immune responses without completely suppressing them, maintaining defense against pathogens
Male preservation: 500-1,000 IU 3x weekly
This product is available in 10mg, 50mg, and 100mg for research use
In pulmonary fibrosis studies using bleomycin-induced injury in mice, doses of 2.6-260 g/mL/day administered every other day from day 4-21 reduced inflammatory cell infiltration, decreased interstitial thickness, and reduced TNF- and IL-6 expression
For a compound to be legally marketed for human therapeutic use in the United States, it must go through the FDA's new drug approval process including Phase I, II, and III clinical trials demonstrating safety and efficacy for a specific indication